Praziquantel paediatric formulation (Pediatric Praziquantel Consortium)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePraziquantel paediatric formulation (Pediatric Praziquantel Consortium)
Drug Alias NameLevo Praziquantel ODTL-praziquantelL-praziquantel orodispersibleRacemate Praziquantel ODTRacemate PZQ ODT +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroid 11-beta-hydroxylase inhibitors
TargetsSteroid 11-beta-hydroxylase
Therapy Area/IndicationsSchistosomiasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTanzaniaGermanyIvory Coast +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPediatric Praziquantel Consortium
China Registration ClassN/A

Develop Information

Active CompaniesMerck KGaA, Darmstadt, Germany
Inactive CompaniesN/A
Active IndicationsSchistosomiasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A